Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Insmed Inc (INSM)

Insmed Inc (INSM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,733,030
  • Shares Outstanding, K 119,975
  • Annual Sales, $ 188,460 K
  • Annual Income, $ -434,650 K
  • 60-Month Beta 1.83
  • Price/Sales 13.60
  • Price/Cash Flow N/A
  • Price/Book 57.73
Trade INSM with:

Options Overview Details

View History
  • Implied Volatility 73.27% ( -20.90%)
  • Historical Volatility 48.85%
  • IV Percentile 57%
  • IV Rank 28.11%
  • IV High 151.85% on 05/11/22
  • IV Low 42.55% on 11/10/21
  • Put/Call Vol Ratio 10.00
  • Today's Volume 11
  • Volume Avg (30-Day) 220
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 8,620
  • Open Int (30-Day) 9,180

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.87
  • Number of Estimates 6
  • High Estimate -0.78
  • Low Estimate -0.92
  • Prior Year -0.96
  • Growth Rate Est. (year over year) +9.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.89 +4.62%
on 09/26/22
25.64 -14.78%
on 09/02/22
-2.32 (-9.60%)
since 08/29/22
3-Month
19.24 +13.57%
on 06/30/22
28.94 -24.50%
on 08/10/22
+1.78 (+8.87%)
since 06/29/22
52-Week
16.41 +33.15%
on 05/12/22
34.44 -36.55%
on 11/04/21
-4.38 (-16.70%)
since 09/29/21

Most Recent Stories

More News
Bluebird (BLUE) Surges 15.7%: Is This an Indication of Further Gains?

Bluebird (BLUE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road....

BLUE : 5.65 (-2.08%)
INSM : 21.58 (-5.27%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

INSM : 21.58 (-5.27%)
Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates

Insmed (INSM) delivered earnings and revenue surprises of 10.11% and 11.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

INSM : 21.58 (-5.27%)
XENE : 35.67 (-2.27%)
Insmed Reports Second Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

INSM : 21.58 (-5.27%)
Earnings Preview: Castle Biosciences, Inc. (CSTL) Q2 Earnings Expected to Decline

Castle Biosciences, Inc. (CSTL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CSTL : 26.04 (-0.19%)
INSM : 21.58 (-5.27%)
Will Insmed (INSM) Report Negative Earnings Next Week? What You Should Know

Insmed (INSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

INSM : 21.58 (-5.27%)
REGN : 691.57 (-1.96%)
Insmed to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

INSM : 21.58 (-5.27%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

INSM : 21.58 (-5.27%)
Insmed (INSM) Reports Q1 Loss, Misses Revenue Estimates

Insmed (INSM) delivered earnings and revenue surprises of 12.09% and 0.98%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

INSM : 21.58 (-5.27%)
LQDA : 5.26 (-4.88%)
Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

INSM : 21.58 (-5.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas...

See More

Key Turning Points

3rd Resistance Point 24.69
2nd Resistance Point 23.82
1st Resistance Point 23.30
Last Price 21.58
1st Support Level 21.92
2nd Support Level 21.05
3rd Support Level 20.53

See More

52-Week High 34.44
Fibonacci 61.8% 27.55
Fibonacci 50% 25.42
Fibonacci 38.2% 23.30
Last Price 21.58
52-Week Low 16.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar